The FDA recently warned that lamotrigine, an antiseizure medication primarily sold under the name Lamictal, could be harmful for patients with certain cardiac conditions. The warning left some healthcare providers feeling confused—after all, they…

Catheter ablation is a more beneficial treatment option for heart failure patients with atrial fibrillation (AFib) than standard antiarrhythmic drug therapy, according to new findings published in Circulation.

“AFib and heart…

Drinking certain energy drinks may cause significant damage to the heart, according to new findings published in Food and Chemical Toxicology. 

“Because the consumption of these beverages is not regulated and they are widely…

Researchers have found that using an AI-based analysis tool can make implantable loop recorders (ILRs) more effective at detecting atrial fibrillation (AFib) episodes.

The team’s findings, published in JACC: Clinical…

High blood pressure can directly lead to atrial fibrillation (AFib), according to new findings published in the European Journal of Preventive Cardiology. The study’s authors noted that this is yet another reason to monitor blood…

Sudden cardiac arrest can be much more fatal when a patient is already battling COVID-19, according to a new study published in European Heart Journal. This is true for both out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac…

A new feature in the Apple iPhone 12 appears to have an unexpected—and potentially dangerous—side effect: it can deactivate a person’s implantable cardiac device.

Cardiologists at the Henry Ford Heart & Vascular Institute discovered…

Direct oral anticoagulants (DOACs) and warfarin are equally effective as a treatment option for atrial fibrillation (AFib) patients with bioprosthetic heart valves (BHVs), according to a new study published in the American Journal of…

The FDA has announced a recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode, a key component of the company’s S-ICD system. This is a Class I recall, which means it is an especially serious issue that can result in injury or death…

Even with numerous vaccines now being distributed, the COVID-19 pandemic continues to cause havoc for health systems all over the world. Numerous studies have confirmed that patients with cardiovascular disease face an especially high risk of…

The wealthiest European countries have higher death rates from atrial fibrillation (AFib) than less wealthy countries, according to a new analysis published in European Heart Journal.

The study’s authors examined data from 1990…

Medtronic has received FDA approval for its DiamondTemp Ablation (DTA) system, a temperature-controlled solution designed to treat patients with recurrent atrial fibrillation (AFib).

The DTA system uses pulmonary vein isolation and can…

Atrial fibrillation (AFib) patients hospitalized with COVID-19 face a heightened risk of poor outcomes, including death, according to a new meta-analysis published in the American Journal of Cardiology.

The study’s authors hoped…

The American Heart Association (AHA) has published a new scientific statement examining the powerful impact a person’s mental health can have on their cardiovascular health.

The statement, published in full in Circulation, was…

Cardiovascular conditions occur at an especially high rate among male breast cancer patients, according to new findings presented as part of the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient virtual…

Atrial fibrillation (AFib) ablation is an effective treatment option for patients with hypertrophic cardiomyopathy (HCM), according to new findings published in the Journal of the American Heart Association.

The study included 65…

Sudden cardiac death (SCD) is more common during nighttime hours for women than men, according to new research out of Cedars-Sinai Medical Center.

SCD, when a disturbance of someone’s heart rhythm causes their heart to stop beating,…

Drinking even a small amount of alcohol can increase a person’s risk of atrial fibrillation (AFib), according to new research published in European Heart Journal.

Tracking data from more than 107,000 patients, researchers found…

Patients with atrial fibrillation (AFib) who are treated with non‐vitamin K antagonist oral anticoagulants (NOACs) are less likely to develop diabetes than those treated with warfarin, according to an in-depth analysis out of Taiwan.

The…

The American College of Cardiology (ACC) is celebrating the holiday season with a new gift for cardiologists: antithrombotic therapy recommendations for patients with atherosclerotic cardiovascular disease (ASCVD) and concomitant atrial…

Royal Philips has acquired BioTelemetry, a Pennsylvania-based healthcare technology company focused on remote cardiac diagnostics and monitoring, for $2.8 billion.

BioTelemetry was founded in 2004, when it was known as CardioNet. The…